Literature DB >> 2986247

Development of three human small cell lung cancer models in nude mice.

H H Fiebig, H A Neumann, H Henss, H Koch, D Kaiser, H Arnold.   

Abstract

The transplantation of seven human small cell lung cancers (SCLC) into athymic nude mice resulted in the development of three tumor lines that are suitable for study of biology and for tests of new drugs and combinations. They were characterized and the response to known drugs was determined. An identical tumor response was observed in the nude mouse system and in the patient in all four comparisons available.

Entities:  

Mesh：

Year:  1985        PMID： 2986247     DOI： 10.1007/978-3-642-82372-5_8

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  24 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  A Melanoma Patient-Derived Xenograft Model.

Authors:  Min Xiao; Vito W Rebecca; Meenhard Herlyn
Journal:  J Vis Exp       Date:  2019-05-20       Impact factor: 1.355

Review 3.  Studying lung cancer in the laboratory: 1--Development of model systems.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 4.  Studying lung cancer in the laboratory--2: Chemosensitivity testing.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

Review 5.  Modeling head and neck cancer stem cell-mediated tumorigenesis.

Authors:  Alexander T Pearson; Trachette L Jackson; Jacques E Nör
Journal:  Cell Mol Life Sci       Date:  2016-05-05       Impact factor: 9.261

6.  In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.

Authors:  H H Fiebig; D P Berger; K Köpping; H C Ottenheijm; Z Zylicz
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Modulation of Bax and mTOR for Cancer Therapeutics.

Authors:  Rui Li; Chunyong Ding; Jun Zhang; Maohua Xie; Dongkyoo Park; Ye Ding; Guo Chen; Guojing Zhang; Melissa Gilbert-Ross; Wei Zhou; Adam I Marcus; Shi-Yong Sun; Zhuo G Chen; Gabriel L Sica; Suresh S Ramalingam; Andrew T Magis; Haian Fu; Fadlo R Khuri; Walter J Curran; Taofeek K Owonikoko; Dong M Shin; Jia Zhou; Xingming Deng
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

Review 8.  Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.

Authors:  Tsutomu Kawaguchi; Barbara A Foster; Jessica Young; Kazuaki Takabe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-04-27       Impact factor: 2.673

9.  In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.

Authors:  G H Leder; H H Fiebig; E Wallbrecher; B R Winterhalter; G W Löhr
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

Review 10.  Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.

Authors:  P Zarzosa; N Navarro; I Giralt; C Molist; A Almazán-Moga; I Vidal; A Soriano; M F Segura; R Hladun; A Villanueva; S Gallego; J Roma
Journal:  Clin Transl Oncol       Date:  2016-10-07       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.